Results indicated that treatment of periodontal disease substantially improved inflammation (as evidenced by reduced CRP levels) in patients without cancer; however, periodontal treatment in cancer survivors did not yield a significant reduction in inflammation, suggesting that cancer survivors may need additional oral health promotion and treatment beyond standard of care for non-cancer patients [6]. This evidence concerns the gene CRP and cancer.